SM
MDGL icon

Sabby Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Sabby Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Hold
0
– – – 107
2018
Q4 		– Sell
-1,500
Closed -$232K – 142
2018
Q3 		$321K Buy
+1,500
New +$376K 0.26% 85
2018
Q2 		– Hold
0
– – – 165
2015
Q2 		– Sell
-11,400
Closed -$794K – 378
2015
Q1 		$794K Buy
+11,400
New +$978K 0.22% 209
2013
Q4 		– Sell
-7,170
Closed -$1.58M – 258
2013
Q3 		$1.58M Buy
7,170
+991
+16% +$211K 0.89% 101
2013
Q2 		$1.08M Buy
+6,179
New +$1.61M 0.58% 115

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return